Versha Banerji

机构：CancerCare Manitoba, Research Institute in Oncology and Hematology, University of Manitoba · ORCID：0000-0002-7415-8818

发表论文 166 篇 · 总被引 3191 次 · h-index 26

代表论文

• AI is a viable alternative to high throughput screening: a 318-target study (2024 · Scientific Reports · 被引 140)
• Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN (2023 · Blood · 被引 52)
• Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN (2025 · Blood · 被引 47)
• Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma (2023 · Nature Communications · 被引 19)
• Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms (2024 · Leukemia · 被引 14)
• PI3K-dependent reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes (2024 · iScience · 被引 12)